ConductScience.org, home

Paper42889337PubMed

Microbiome-Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease.

Maghembe RS and 3 others. FASEB Bioadv, 2026.

Cite this record

ConductScience Library. Microbiome-Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease. Papers, record 42889337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42889337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microbiome-Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease.
Journal
FASEB Bioadv
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-19

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maghembe RSReuben Shttps://orcid.org/0000-0003-2453-5993
2Damian DDonath
3Bahati SSamweli
4Makaranga AAbdalah

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118305141Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.Diabetes2008https://conductscience.org/library/papers/18305141PubMed
235634468The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism.Front Cell Neurosci2022https://conductscience.org/library/papers/35634468PubMed
327315476Modeling Development and Disease with Organoids.Cell2016https://conductscience.org/library/papers/27315476PubMed
438790705Therapeutic Potential of Palmitoylethanolamide in Gastrointestinal Disorders.Antioxidants (Basel)2024https://conductscience.org/library/papers/38790705PubMed
528596366Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.Science2017https://conductscience.org/library/papers/28596366PubMed
632457482Host-microbiota interactions in immune-mediated diseases.Nat Rev Microbiol2020https://conductscience.org/library/papers/32457482PubMed
728476144Multi-omics approaches to disease.Genome Biol2017https://conductscience.org/library/papers/28476144PubMed
837431863Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis.Gut Microbes2023https://conductscience.org/library/papers/37431863PubMed
940283915Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40283915PubMed
1021471961The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.Mucosal Immunol2011https://conductscience.org/library/papers/21471961PubMed
1134069940Palmitoylethanolamide: A Natural Compound for Health Management.Int J Mol Sci2021https://conductscience.org/library/papers/34069940PubMed
1227413788Endocannabinoids in the Gut.Cannabis Cannabinoid Res2016https://conductscience.org/library/papers/27413788PubMed
1332433595Interaction between microbiota and immunity in health and disease.Cell Res2020https://conductscience.org/library/papers/32433595PubMed
1421862983The microbiome and rheumatoid arthritis.Nat Rev Rheumatol2011https://conductscience.org/library/papers/21862983PubMed
1533494185GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide.Int J Mol Sci2021https://conductscience.org/library/papers/33494185PubMed
1636778747The Gut Microbiome-Endocannabinoidome Axis: A New Way of Controlling Metabolism, Inflammation, and Behavior.Function (Oxf)2023https://conductscience.org/library/papers/36778747PubMed
1737735572Dietary food patterns as determinants of the gut microbiome-endocannabinoidome axis in humans.Sci Rep2023https://conductscience.org/library/papers/37735572PubMed
1828530168Microbe Profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa.Microbiology (Reading)2017https://conductscience.org/library/papers/28530168PubMed
1936977462Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections.Open Biol2023https://conductscience.org/library/papers/36977462PubMed
2027646959Tolerogenic dendritic cells.Semin Immunopathol2017https://conductscience.org/library/papers/27646959PubMed

See all 90 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42889337

GET https://conductscience.org/api/papers/v1/42889337/references?page=2